Application of EU Tissue and Cell Directive screening protocols to anonymous oocyte donors in western Ukraine: Data from an Irish IVF programme

Journal of Obstetrics and Gynaecology

Volumn 30, Issue 6, 2010, Pages 613-616

  Walsh, A P H ^a   Omar, A B ^a   Collins, G S ^b   Murray, G U ^a   Walsh, D J ^a   Salma, U ^a   Sills, E Scott ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Donor oocyte; Hepatitis; HIV; IVF; Screening; Ukraine

Indexed keywords

ADULT; ANONYMOUS TESTING; ARTICLE; CLINICAL PROTOCOL; EUROPEAN UNION; FEMALE; FERTILIZATION IN VITRO; GAMETE; HEALTH PROGRAM; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFERTILITY THERAPY; IRELAND; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE DONATION; OOCYTE RETRIEVAL; PATIENT SAFETY; PRIORITY JOURNAL; SCREENING TEST; UKRAINE;

EUROPEAN UNION; FEMALE; FERTILIZATION IN VITRO; HUMANS; OOCYTE DONATION; TISSUE DONORS; UKRAINE;

EID: 77955538507     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2010.497875     Document Type: Article

References (22)

1. Blyth E. 2004. Patient experiences of an egg sharing programme. Human Fertility (Cambridge) 7:157-162.
2. Bodri D, Colodron M, Vidal R, Galindo A, Durban M, Coll O. 2007. Prognostic factors in oocyte donation: an analysis through egg-sharing recipient pairs showing a discordant outcome. Fertility and Sterility 88:1548-1553.
3. Brett S, Sacranie RR, Thomas GE, Rajkhowa R. 2008. Can we improve recruitment of oocyte donors with loss of donor anonymity? A hospital-based survey. Human Fertility (Cambridge) 11:101-107.
4. Craig P, de Bú rca G. 2007. European union law: text, cases and materials. 4th ed. Oxford: Oxford University Press. p 402.
5. Directive 2004/23/EC. 2004. Directive of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Journal of the European Union 102:48-58.
6. ESHRE. 2009. Statement of the European Society of Human Reproduction and Embryology (ESHRE) on the European Commission proposal of viral screening in assisted reproduction treatments. ESHRE Press Office, 16 November.
7. Fortescue E. 2003. Gamete donation-where is the evidence that there are benefits in removing the anonymity of donors? A patients viewpoint. Reproductive Biomedicine Online 7:139-144.
8. Irish Medicines Board. 2007. Draft guidance for consultation on serological testing requirements for donors of reproductive cells, 28 September. Available at: www.imb.ie/images/uploaded/documents/draft%20guidance.pdf
9. Jones CA, Keith LG. 2006. Medical tourism and reproductive outsourcing: the dawning of a new paradigm for healthcare. International Journal of Fertility and Womens Medicine 51:251-255.
10. McDonald S. 2002. Global considerations-Science and the regulation of biological products. Food and Drug Administration (USA). Washington, DC: USGPO. p 34.
11. Merlet F, Sénémaud B. 2009. Egg donation: Regulation of the donation and the hidden face of the cross-border reproductive care. Gynécologie Obstétrique and Fertilité 38:36-44.
12. Ministry of Health (Ukraine). 2002. Oocyte Donation. Order No. 177. Ukraine: Ministry of Health.
13. Mullin CM, Fino ME, Talebian S, Keegan D, Grifo JA, Licciardi F. 2010. Comparison of pregnancy outcomes in anonymous shared versus exclusive donor oocyte in vitro fertilization cycles. Fertility and Sterility 93:574-578.
14. Murphy TF. 2009. Ethics and the prohibition of donor gametes in fertility medicine. Reproductive Biomedicine Online 18:S60-S67.
15. Oyesanya OA, Olufowobi O, Ross W, Sharif K, Afnan M. 2009. Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization-embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors. Fertility and Sterility 92:930-936.
16. Roest J, Verhoeff A, van Lent M, Huisman GJ, Zeilmaker GH. 1995. Results of decentralized in-vitro fertilization treatment with transport and satellite clinics. Human Reproduction 10:563-567.
17. Sachs P, Covington SN, Toll C, Richter KS, Purcell M, Chang FE. 2010. Demographic variables related to successful anonymous oocyte donor recruitment. Fertility and Sterility 93:311-313.
18. Sills ES, Murphy SE. 2009. Determining the status of nontransferred embryos in Ireland: a conspectus of case law and implications for clinical IVF practice. Philosophy, Ethics, and Humanities in Medicine 4:8.
19. Sills ES, Murray GU, Genton MG, Walsh DJ, Coull GD, Walsh AP. 2009. Clinical features and reproductive outcomes for embryos undergoing dual freeze-thaw sequences followed by blastocyst transfer: critique of 14 consecutive cases in IVF. Fertility and Sterility 91:S1568-S1570.
20. UNAIDS. 2009. UNAIDS/09.10E/JC1676E. Monitoring the Declaration of Commitment on HIV/AIDS: Guidelines on construction of core indicators: 2010 reporting. Geneva: United Nations. p 12, 19, 40-41.
21. Walsh AP, Shkrobot LV, Coull GD, Peirce KL, Walsh DJ, Salma U, et al. 2009. Blastocyst transfer for multiple prior IVF failure: a five year descriptive study. Irish Medical Journal 102:282-285.
22. Yushchenko V. 2008. Forward. Ukraine: National Report on Monitoring Progress Towards the UNGASS Declaration of Commitment on HIV/AIDS (Reporting period January 2006-December 2007). Ukraine: Ministry of Health 3.